Chronic bronchitis: Causes, symptoms, and care

Written by: Dr Shalin Diwanji
Published:
Edited by: Kate Forristal

Bronchitis, an inflammation of the mucous membranes lining the airways in the lungs, can be a debilitating condition, especially when it becomes chronic. Chronic bronchitis, defined as lasting more than three months for two consecutive years, poses significant challenges to those affected. In his latest online article, Dr Shalin Diwanji delves into the causes, symptoms, and management strategies for this condition.

Causes:

The primary culprit behind chronic bronchitis is smoking. The inhalation of cigarette smoke damages the cilia, the hair-like structures responsible for clearing debris and irritants from the airways. This damage leads to inflammation and thickening of the mucous membranes, resulting in airway obstruction. However, smoking is not the sole cause; exposure to dusty environments, toxic gases, and air pollution can also contribute to the development of chronic bronchitis.

 

Symptoms:

Recognising the symptoms of chronic bronchitis is crucial for early diagnosis and management. Individuals with chronic bronchitis may experience persistent coughing, chest pain or tightness, wheezing, and fatigue. These symptoms can overlap with those of other respiratory conditions, such as asthma, pneumonia, or even lung cancer. Therefore, it is essential to seek medical attention if any of the following symptoms persist:

  • Shortness of breath or wheezing
  • Cough lasting more than four weeks
  • Fever exceeding 101°F
  • Presence of blood in the mucus

 

Diagnosis and management:

Upon presentation to a healthcare provider, a thorough evaluation is conducted to confirm the diagnosis of chronic bronchitis. This typically involves a comprehensive review of medical history, a physical examination—including auscultation of the chest with a stethoscope—and diagnostic tests such as chest X-rays and lung function assessments.

 

The cornerstone of managing chronic bronchitis is smoking cessation. Quitting smoking can halt the progression of the disease and significantly improve lung function. Additionally, lifestyle modifications, such as avoiding lung irritants and maintaining good respiratory hygiene, are recommended.

 

During exacerbations of chronic bronchitis, patients are advised to rest and increase fluid intake to help alleviate symptoms. Depending on the severity of symptoms, healthcare providers may prescribe medications such as bronchodilators or steroids to provide relief and reduce inflammation.

 

Preventive measures, including annual vaccinations against pneumonia and influenza, are essential for individuals with chronic bronchitis to minimise the risk of respiratory infections. In some cases, supplemental oxygen therapy and pulmonary rehabilitation programmes may be beneficial in improving respiratory function and quality of life.

 

Dr Shalin Diwanji is an esteemed consultant in respiratory and general medicine. You can schedule an appointment with Dr Diwanji on his Top Doctors profile.

By Dr Shalin Diwanji
Pulmonology & respiratory medicine

Dr Shalin Diwanji is a highly esteemed consultant in respiratory and general medicine based in London who specialises in asthma, chronic cough, airway disease, lung cancer, breathlessness and bronchoscopy procedures. With over 17 years of specialist experience, Dr Diwanji sees private patients at The Princess Grace Hospital & London Digestive Centre. His NHS base is London North West Healthcare NHS Trust, where he is also the lung cancer lead.

Dr Diwanji qualified in 2006 and completed his foundation training in India. He relocated to the UK after to pursue formal research in respiratory medicine, and was awarded an MD in 2010 from The University of Buckingham for his investigation on non-cystic fibrosis bronchiectasis. Dr Diwanji went on to accomplish dual higher specialist training in both general (internal) medicine and respiratory medicine at London Chest Hospital, The Royal London Hospital and St Barts Hospital in London. He is a Fellow of the Royal College of Physicians in the UK since 2019.

Beyond his medical practice, Dr Diwanji is a prominent figure in clinical research, and currently serves as principal investigator for the PHOSP-COVID trial and as sub-investigator for the TRIBE study. He is on the GMC’s specialist register and is also a member of various professional organisations, including the European Respiratory Society and the British Thoracic Society. A trusted expert, Dr Diwanji is widely recognised for his clinical expertise and compassionate patient care, working in partnership with his patients to develop treatment plans that meet their individual needs and ensure good health and wellbeing.

View Profile

Overall assessment of their patients


  • Related procedures
  • Depression
    Sleep disorders
    Snoring
    Rhinitis
    Obstructive sleep apnea
    Restless legs syndrome
    Autoimmune diseases
    Atypical pneumonia
    Asthma
    Methacholine challenge test
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.